三氧化二砷成功治疗一名接受血液透析的急性早幼粒细胞白血病患者。
Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide.
作者信息
Hashimoto Akiko, Tanaka Yasuhiro, Ishikawa Takayuki, Shinzato Isaku
机构信息
Department of Hematology and Clinical Immunology Kobe City Nishi-Kobe Medical Center Kobe Japan.
Department of Hematology Kobe City Hospital Organization Kobe City Medical Center General Hospital Kobe Japan.
出版信息
Clin Case Rep. 2021 Jul 23;9(7):e04417. doi: 10.1002/ccr3.4417. eCollection 2021 Jul.
A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively for APL with CKD.
一名接受血液透析的慢性肾脏病（CKD）患者被诊断为急性早幼粒细胞白血病（APL）。他接受了三氧化二砷单药治疗，实现了完全分子缓解，且无严重不良事件。三氧化二砷（ATO）可安全有效地用于患有CKD的APL患者。
Zotero 插件